MY17
MY17 is an inhibitor of protein tyrosine phosphatase 1B (PTP1B) with an IC50 of 0.41±0.05 μM. It alleviates insulin resistance induced by palmitic acid (PA) by enhancing the expression of phosphorylated insulin receptor substrate (IRS1) and protein kinase B (AKT) . By binding to PTP1B, MY17 inhibits its activity, thereby improving insulin signaling and exhibiting antidiabetic properties. MY17 is useful in the study of type 2 diabetes.
Product Specifications
Field of Research
Metabolism Research
Molecular Formula
C21H13N5O3S3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7150933 Inquire
Rabbit anti-Oryza sativa subsp. indica (Rice) rpl14 Polyclonal Antibody
Sign In for Pricing
View Details 
ARP55186_P050-FITC 100 µL
PHLDB1 Antibody - middle region : FITC (ARP55186_P050-FITC)
Sign In for Pricing
View Details bs-13292R-BF350 100 µL
GIPR Polyclonal Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details